Incidence of hypertension in obstructive sleep apnea using hypopneas defined by 3 percent oxygen desaturation or arousal but not by only 4 percent oxygen desaturation.
OSA
hypopnea definition
incident hypertension
Journal
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977
Informations de publication
Date de publication:
15 10 2020
15 10 2020
Historique:
pubmed:
10
7
2020
medline:
24
6
2021
entrez:
10
7
2020
Statut:
ppublish
Résumé
This analysis determined ∼5-year incident hypertension rates using the 2017 American College of Cardiology/American Heart Association blood pressure (BP) guidelines in individuals with obstructive sleep apnea (OSA) with hypopneas defined by a ≥ 3% oxygen desaturation or arousal but not by a hypopnea criterion of ≥ 4% oxygen desaturation (4% only). Data were analyzed from participants in the Sleep Heart Health Study exam 2 (n = 1219) who were normotensive (BP ≤ 120/80 mm Hg) at exam 1. The AHI at exam 1 was classified into 4 categories of OSA severity: < 5, 5 ≤ 15, 15 ≤ 30, and ≥ 30 events/h using both the 3% oxygen desaturation or arousal and the 4% only definitions. Three definitions of hypertension-elevated BP (> 120/80 mm Hg), stage 1 (> 130/80 mm Hg), and stage 2 (> 140/90 mm Hg)-were used to determine incidence rates at exam 2. Five-year follow-up was available for 476 participants classified as having OSA by the 3% oxygen desaturation or arousal criterion but not by the 4% only standard at exam 1. Incident hypertension using American College of Cardiology/American Heart Association-defined BP categories in these discordantly classified individuals were 15% (elevated BP), 15% (stage 1), and 6% (stage 2). Hypertensive medications were used in 4% of participants who were normotensive. The overall incidence rate of at least an elevated BP was 40% (191/476) in those with OSA defined using the 3% oxygen desaturation or arousal criterion but not by the 4% only criterion. Use of the 4% only hypopnea definition resulted in the failure to identify a significant number of individuals with OSA who eventually developed hypertension and could have benefited from earlier diagnosis and treatment.
Identifiants
pubmed: 32643602
doi: 10.5664/jcsm.8684
pmc: PMC7954019
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1753-1760Subventions
Organisme : NHLBI NIH HHS
ID : U01 HL053916
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL063463
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053938
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL064360
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053937
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053941
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL140144
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053934
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL063429
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053931
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA184920
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2020 American Academy of Sleep Medicine.
Références
Sleep Breath. 2009 Nov;13(4):341-7
pubmed: 19418083
J Clin Sleep Med. 2005 Oct 15;1(4):401-4
pubmed: 17564410
Sleep. 1998 Nov 1;21(7):759-67
pubmed: 11300121
J Clin Sleep Med. 2009 Oct 15;5(5):404-5
pubmed: 19961021
J Korean Med Sci. 2001 Dec;16(6):707-11
pubmed: 11748349
Eur Respir J. 2017 Nov 30;50(5):
pubmed: 29191951
J Clin Sleep Med. 2018 Dec 15;14(12):1987-1994
pubmed: 30518445
J Am Coll Cardiol. 2017 Feb 21;69(7):841-858
pubmed: 28209226
Circulation. 2010 Jul 27;122(4):352-60
pubmed: 20625114
J Clin Sleep Med. 2019 May 15;15(5):687-696
pubmed: 31053203
Am J Respir Crit Care Med. 2009 Jun 15;179(12):1159-64
pubmed: 19264976
JAMA. 2012 May 23;307(20):2169-76
pubmed: 22618924
Sleep Med Clin. 2016 Jun;11(2):241-55
pubmed: 27236060
Chest. 2014 Apr;145(4):762-771
pubmed: 24077181
J Clin Sleep Med. 2007 Jun 15;3(4):409-15
pubmed: 17694731
Chest. 2017 Dec;152(6):1214-1229
pubmed: 28923761
Lancet. 2005 Mar 19-25;365(9464):1046-53
pubmed: 15781100
N Engl J Med. 1993 Apr 29;328(17):1230-5
pubmed: 8464434
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
Sleep. 1997 Dec;20(12):1077-85
pubmed: 9493915
Sleep. 2017 Nov 1;40(11):
pubmed: 29029253
Sleep Breath. 2003 Mar;7(1):13-24
pubmed: 12712393
N Engl J Med. 2000 May 11;342(19):1378-84
pubmed: 10805822
Respir Care. 2010 Oct;55(10):1322-32; discussion 1330-2
pubmed: 20875159
Sleep. 2006 Jun;29(6):777-83
pubmed: 16796216
Am J Epidemiol. 2013 May 1;177(9):1006-14
pubmed: 23589584
J Hypertens. 2014 Dec;32(12):2341-50; discussion 2350
pubmed: 25243523
J Clin Sleep Med. 2009 Apr 15;5(2):108-9
pubmed: 19968041
J Clin Sleep Med. 2019 Sep 15;15(9):1261-1270
pubmed: 31538597
Annu Rev Public Health. 2006;27:465-90
pubmed: 16533126
Sleep Breath. 2004 Sep;8(3):141-6
pubmed: 15389388
J Clin Sleep Med. 2019 Feb 15;15(2):183-194
pubmed: 30736872
JAMA. 2015 Dec 1;314(21):2280-93
pubmed: 26624827
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Sleep Med. 2013 Nov;14(11):1123-31
pubmed: 24047534
Lancet Respir Med. 2015 Apr;3(4):310-8
pubmed: 25682233
Sleep. 1998 Nov 1;21(7):749-57
pubmed: 11286351